Legal Representation
Attorney
Jennifer D. Arkowitz, Esq.
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 7, 2010 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 7, 2010 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Nov 4, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 4, 2009 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 4, 2009 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 5, 2009 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 10, 2009 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 21, 2009 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jan 6, 2009 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jan 5, 2009 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 17, 2008 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 17, 2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 17, 2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 4, 2008 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 4, 2008 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 4, 2008 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 4, 2008 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 4, 2008 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 29, 2008 | MPMK | O | NOTICE OF PSEUDO MARK MAILED | Loading... |
| Feb 28, 2008 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals, namely, pharmaceutical preparations having enhanced drug performance and/or drug delivery performance for the treatment and/or prophylaxis of diseases or medical conditions such as diabetes, infections, cancers, and inflammations, or of diseases or medical conditions that affect the peripheral nerves, the adrenergic and/or cholinergic receptors, the histamine receptors, the expression and/or regulation of growth factors, the skeletal and/or smooth muscle systems, the cardiovascular system, the endocrine and/or hormone systems, the blood circulatory system, the immunological system, the synoptic and neuroeffector junctional sites, the reproductive system, the skeletal system, the autocoid system, the alimentary and/or excretory systems, and/or the central nervous system
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Inhaler devices, sold empty, used to introduce medication into the respiratory system as fine liquid mist for the treatment of respiratory and pulmonary conditions; medical devices, namely, medical apparatus in the nature of a unit for aerosol drug delivery to the deep lung of drugs as fine, dry particles
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Research services, namely, providing research and development services for others in the biotechnical, biomedical and pharmaceutical fields
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
NECTAR DPT
Classification
International Classes
005
010
042